Stay updated on OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial
Sign up to get notified when there's something new on the OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial page.

Latest updates to the OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial page
- Check5 days agoChange DetectedThe page history now reflects a new site revision label (v3.6.5). The previous revision (v3.6.4) has been removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4. This indicates an incremental update to the page version history rather than a change to study data or content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label on the Record History page updated to v3.6.3, indicating a new build/version of the page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe record now shows the study was terminated in February 2026 after an interim analysis, with enrollment suspended since December 22, 2025, and no longer recruiting participants; key sections including Contacts/Locations, Study Design, Study Status, and Recruitment Status were updated, with a final analysis planned for Q2 2026.SummaryDifference0.7%

- Check62 days agoChange DetectedThe record history updates to v3.6.0 and removes v3.5.5, reflecting the latest revision in the history log, and adds quick links 'Check who can join' and 'Find Contact Information' for easier navigation.SummaryDifference0.3%

- Check69 days agoChange DetectedA new revision (v3.5.5) is added to the record history. The previous revision (v3.5.4) is removed, updating the study's audit trail.SummaryDifference0.1%

Stay in the know with updates to OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OCTAPLEX Study in DOAC-Related Major Bleeding Clinical Trial page.